22 Sep 2010
(MENAFN) Dubai-based NewBridge Pharmaceuticals said that it has completed its $12 million Series B financing, bringing the total amount raised to $16 million, Reuters reported.
The Series B financing round was led by Kuwait Life Sciences Company (KLSC), a subsidiary of National Technology Enterprises Company of Kuwait with participation by the previous investor Burrill Life Sciences Capital Fund III, L.P.
NewBridge is a specialty pharmaceutical, biologics, medical devices and diagnostics company serving the emerging markets of Africa, Middle East, Turkey, and Caspian regions.
08 Apr 2026
BBK awards over BD 1 Million to 273 winners in the February Al Hayrat Grand Prizes draw
01 Mar 2026
BBK activates partial remote working system for its workforce to ensure employee and customer safety and service continuity
24 Feb 2026
BBK discloses its financial results for the year ended 31st December 2025
05 Feb 2026
BBK announces December Al Hayrat Grand Prize winners and another wave of Grand prizes for February
This website uses cookies to ensure you get the best experience and by clicking “I Accept” below, you consent to the use of cookies. Learn more